Negative predictive value of PSMA PET scan for lymph node staging in patients undergoing robotic radical prostatectomy and pelvic lymph node dissection

Int Urol Nephrol. 2023 Jun;55(6):1453-1457. doi: 10.1007/s11255-023-03595-0. Epub 2023 Apr 22.

Abstract

Purpose: To assess the negative predictive value of PSMA PET scan for lymph node staging in patients undergoing robotic radical prostatectomy and pelvic lymph node dissection.

Materials and methods: A retrospective analysis of patients who underwent robotic-assisted radical prostatectomy with pelvic lymph node dissection and had a preoperative negative PSMA PET scan for metastasis was performed. The documented pre-operative variables studied included age, BMI, PSA at diagnosis, Gleason score, and biopsy ISUP grades. Patients were categorised as low, intermediate and high risk according to the D Amico classification. The post-op variables included were number of lymph nodes harvested, number of positive nodes, positivity rate, size of the node metastasis, T staging and ISUP grading.

Results: The overall negative predictive value of PSMA PET scan was 71.6%. Further sub-classification according to risk stratification demonstrated a NPV of 58.02%, 92.7% and 90% for high, intermediate and low risk, respectively.

Conclusion: Pelvic lymph node dissection cannot be excluded based on a negative preop PSMA PET/CT scan.

Keywords: Lymph node dissection; Lymph node metastasis; PET scan; PSMA PET scan; Prostate cancer; Robotic radical prostatectomy.

MeSH terms

  • Gallium Radioisotopes
  • Humans
  • Lymph Node Excision
  • Lymph Nodes / pathology
  • Male
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography
  • Predictive Value of Tests
  • Prostatectomy
  • Retrospective Studies
  • Robotic Surgical Procedures*

Substances

  • Gallium Radioisotopes